Table 2.
The univariate analysis of independent prognostic models
| Clinical factor | HR | HR.95 L | HR.95 H | p |
|---|---|---|---|---|
| age | 1.03 | 1.01 | 1.05 | 0.000275*** |
| Loss Expression of MMR Proteins | 0.23 | 0.07 | 0.73 | 0.012971* |
| Lymphatic invasion | 1.89 | 1.29 | 2.77 | 0.001057** |
| Risk score | 1.52 | 1.33 | 1.74 | 8.35E-10*** |
| pathologic M | 4.32 | 2.9 | 6.44 | 5.96E-13*** |
| pathologic N(reference: N0) | ||||
| N1 | 1.900343802 | 1.206960394 | 2.992067168 | 0.005568** |
| N2 | 3.961218249 | 2.611668465 | 6.008132437 | 9.37E-11*** |
| pathologic T(reference: T0) | ||||
| T4 | 6.15 | 1.46 | 26 | 0.013490* |
|
Tumor stage (reference: I) | ||||
| III | 3.35 | 1.41 | 7.94 | 0.006098** |
| IV | 9.13 | 3.87 | 21.55 | 4.46E-07*** |
HR Hazards ratio
*p < 0.05, **p < 0.01, ***p < 0.001